132 related articles for article (PubMed ID: 23045516)
1. Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?
Biganzoli L; Boni L; Becheri D; Zafarana E; Biagioni C; Cappadona S; Bianchini E; Oakman C; Magnolfi SU; Di Leo A; Mottino G
Ann Oncol; 2013 Feb; 24(2):494-500. PubMed ID: 23045516
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation.
Mohile SG; Bylow K; Dale W; Dignam J; Martin K; Petrylak DP; Stadler WM; Rodin M
Cancer; 2007 Feb; 109(4):802-10. PubMed ID: 17219443
[TBL] [Abstract][Full Text] [Related]
3. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13.
Luciani A; Ascione G; Bertuzzi C; Marussi D; Codecà C; Di Maria G; Caldiera SE; Floriani I; Zonato S; Ferrari D; Foa P
J Clin Oncol; 2010 Apr; 28(12):2046-50. PubMed ID: 20308657
[TBL] [Abstract][Full Text] [Related]
4. Identifying an accurate pre-screening tool in geriatric oncology.
Kellen E; Bulens P; Deckx L; Schouten H; Van Dijk M; Verdonck I; Buntinx F
Crit Rev Oncol Hematol; 2010 Sep; 75(3):243-8. PubMed ID: 20060313
[TBL] [Abstract][Full Text] [Related]
5. PPT and VES-13 in elderly patients with cancer: evaluation in multidimensional geriatric assessment and prediction of survival.
Augschoell J; Kemmler G; Hamaker ME; Stauder R
J Geriatr Oncol; 2014 Oct; 5(4):415-21. PubMed ID: 25242575
[TBL] [Abstract][Full Text] [Related]
6. Vulnerable Elderly Survey 13 as a screening method for frailty in Polish elderly surgical patient--prospective study.
Kenig J; Richter P; Zychiewicz B; Olszewska U
Pol Przegl Chir; 2014 Mar; 86(3):126-31. PubMed ID: 24791815
[TBL] [Abstract][Full Text] [Related]
7. The importance of negative predictive value (NPV) of vulnerable elderly survey (VES 13) as a pre-screening test in older patients with cancer.
Castagneto B; Di Pietrantonj C; Stevani I; Anfossi A; Arzese M; Giorcelli L; Giaretto L
Med Oncol; 2013 Dec; 30(4):708. PubMed ID: 23996243
[TBL] [Abstract][Full Text] [Related]
8. Gait Speed vs. VES-13: A Pilot Study Comparing Screening Tools to Determine the Need for a Comprehensive Geriatric Assessment in Senior Women with Breast Cancer.
Hollenberg DC; Menjak IB; Mehta R; Bristow B; Trudeau ME; Gibson L; Neve M; Norris M; Pasetka M; Rice K; McCullock F; Wright FC; Szumacher E
J Med Imaging Radiat Sci; 2019 Dec; 50(4):551-556. PubMed ID: 31780434
[TBL] [Abstract][Full Text] [Related]
9. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review.
Hamaker ME; Jonker JM; de Rooij SE; Vos AG; Smorenburg CH; van Munster BC
Lancet Oncol; 2012 Oct; 13(10):e437-44. PubMed ID: 23026829
[TBL] [Abstract][Full Text] [Related]
10. Role of the vulnerable elders survey-13 screening tool in predicting treatment plan modification for older adults with cancer.
Almugbel FA; Timilshina N; AlQurini N; Loucks A; Jin R; Berger A; Romanovsky L; Puts M; Alibhai SMH
J Geriatr Oncol; 2021 Jun; 12(5):786-792. PubMed ID: 33342723
[TBL] [Abstract][Full Text] [Related]
11. Vulnerability in elderly patients with gastrointestinal cancer--translation, cultural adaptation and validation of the European Portuguese version of the Vulnerable Elders Survey (VES-13).
Carneiro F; Sousa N; Azevedo LF; Saliba D
BMC Cancer; 2015 Oct; 15():723. PubMed ID: 26475578
[TBL] [Abstract][Full Text] [Related]
12. Geriatric oncology screening tools for CGA-based interventions: results from a phase II study of geriatric assessment and management for older adults with cancer.
Yokom DW; Alibhai SMH; Sattar S; Krzyzanowska MK; Puts MTE
J Geriatr Oncol; 2018 Nov; 9(6):683-686. PubMed ID: 29540293
[TBL] [Abstract][Full Text] [Related]
13. Screening for Frailty in Older Patients With Early-Stage Solid Tumors: A Prospective Longitudinal Evaluation of Three Different Geriatric Tools.
Biganzoli L; Mislang AR; Di Donato S; Becheri D; Biagioni C; Vitale S; Sanna G; Zafarana E; Gabellini S; Del Monte F; Mori E; Pozzessere D; Brunello A; Luciani A; Laera L; Boni L; Di Leo A; Mottino G
J Gerontol A Biol Sci Med Sci; 2017 Jul; 72(7):922-928. PubMed ID: 28158486
[TBL] [Abstract][Full Text] [Related]
14. Performance of the Vulnerable Elders Survey 13 screening tool in identifying cancer treatment modification after geriatric assessment in pre-treatment patients: A retrospective analysis.
Rowbottom L; Loucks A; Jin R; Breunis H; Syed AT; Watt S; Timilshina N; Puts M; Yokom D; Berger A; Alibhai SMH
J Geriatr Oncol; 2019 Mar; 10(2):229-234. PubMed ID: 30420323
[TBL] [Abstract][Full Text] [Related]
15. Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13).
Luciani A; Biganzoli L; Colloca G; Falci C; Castagneto B; Floriani I; Battisti N; Dottorini L; Ferrari D; Fiduccia P; Zafarana E; Del Monte F; Galli F; Monfardini S; Foa P
J Geriatr Oncol; 2015 Jul; 6(4):272-9. PubMed ID: 26088748
[TBL] [Abstract][Full Text] [Related]
16. Four screening instruments for frailty in older patients with and without cancer: a diagnostic study.
Smets IH; Kempen GI; Janssen-Heijnen ML; Deckx L; Buntinx FJ; van den Akker M
BMC Geriatr; 2014 Feb; 14():26. PubMed ID: 24571290
[TBL] [Abstract][Full Text] [Related]
17. [Cancer treatment in elderly patients: evidence and clinical research].
Repetto L; Luciani A
Recenti Prog Med; 2015 Jan; 106(1):23-7. PubMed ID: 25621776
[TBL] [Abstract][Full Text] [Related]
18. Use of geriatric assessment and screening tools of frailty in elderly patients with prostate cancer. Review.
Molina-Garrido MJ; Guillén-Ponce C
Aging Male; 2017 Jun; 20(2):102-109. PubMed ID: 28084133
[TBL] [Abstract][Full Text] [Related]
19. A Questionnaire Study to Assess the Value of the Vulnerable Elders Survey, G8, and Predictors of Toxicity as Screening Tools for Frailty and Toxicity in Geriatric Cancer Patients.
Hentschel L; Rentsch A; Lenz F; Hornemann B; Schmitt J; Baumann M; Ehninger G; Schuler M
Oncol Res Treat; 2016; 39(4):210-6. PubMed ID: 27160741
[TBL] [Abstract][Full Text] [Related]
20. Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life.
Pottel L; Lycke M; Boterberg T; Pottel H; Goethals L; Duprez F; Van Den Noortgate N; De Neve W; Rottey S; Geldhof K; Buyse V; Kargar-Samani K; Ghekiere V; Debruyne PR
Eur J Cancer Care (Engl); 2014 May; 23(3):401-12. PubMed ID: 24467393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
